| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/11/2009 | EP2021469A2 Peptide library |
| 02/11/2009 | EP2021468A2 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
| 02/11/2009 | EP2021467A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 02/11/2009 | EP2021457A2 Probiotic strain and antimicrobial peptide derived therefrom |
| 02/11/2009 | EP2021368A1 Derivatized insulin oligomers |
| 02/11/2009 | EP2021365A2 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases |
| 02/11/2009 | EP2021364A1 Improved antimicrobial peptides |
| 02/11/2009 | EP2021363A1 Polypeptides and polynucleotides encoding the same |
| 02/11/2009 | EP2021356A2 Hiv vaccine |
| 02/11/2009 | EP2021354A2 N-terminally modified glp-1 receptor modulators |
| 02/11/2009 | EP2021353A2 Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application |
| 02/11/2009 | EP2021035A2 Cell-matrix microspheres, methods for preparation and applications |
| 02/11/2009 | EP2021033A2 Il-1 immunization induces autoantibodies protective against atherosclerosis |
| 02/11/2009 | EP2021015A2 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 02/11/2009 | EP2021014A1 Sustained release glp-1 receptor modulators |
| 02/11/2009 | EP2021013A2 Tracheal cytotoxin (tct) and related compounds for suppressing immune responses |
| 02/11/2009 | EP2021012A1 Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake |
| 02/11/2009 | EP2021011A2 Methods of use and nutritional compositions of touchi extract |
| 02/11/2009 | EP2021009A2 Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure |
| 02/11/2009 | EP2020991A2 A direct cellular energy delivery system |
| 02/11/2009 | EP2020988A2 Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
| 02/11/2009 | EP1796646B1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 02/11/2009 | EP1701978B1 Use of soluble T-Cadherin for the treatment of metabolic disorders |
| 02/11/2009 | EP1648929B1 Active subfragments of human histidine rich glycoprotein |
| 02/11/2009 | EP1636340A4 Unnatural reactive amino acid genetic code additions |
| 02/11/2009 | EP1622601B1 Pharmaceutical compositions |
| 02/11/2009 | EP1572679B1 Crfr1 selective ligands |
| 02/11/2009 | EP1549950B1 Methods for identifying glucose uptake modulators |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1458747B1 Template-fixed peptidomimetics as inhibitors of serine proteases |
| 02/11/2009 | EP1429800B1 Vaccine and use thereof for treatment of amyotrophic lateral sclerosis |
| 02/11/2009 | EP1317258B1 Use of allopurinol for the treatment of hypertension |
| 02/11/2009 | EP1309334B1 Combination therapy using reovirus and anti-antireovirus antibodies for the treatment of ras-mediated proliferative disorders |
| 02/11/2009 | EP1259536B1 Methods of peptide preparation |
| 02/11/2009 | EP1210453B1 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 02/11/2009 | EP1140164B1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 02/11/2009 | EP1042466B1 Polypeptides, polynucleotides and uses thereof |
| 02/11/2009 | EP0954286B1 Liposomal influenza vaccine composition and method |
| 02/11/2009 | EP0784059B1 Polynucleotides encoding an antigenic polypeptide of chlamydia pneumoniae |
| 02/11/2009 | CN101365784A Methods of specifying mesodermal, endodermal and mesoendodermal cell fates |
| 02/11/2009 | CN101365783A Production of glycoproteins with reduced o-glycosylation |
| 02/11/2009 | CN101365717A Screening method, process for purifying of non-diffusible A-beta oligomers, selective antibodies against said non-diffusible A-beta oligomers and a process for manufacturing of said antibodies |
| 02/11/2009 | CN101365712A Pan-her antagonists and methods of use |
| 02/11/2009 | CN101365492A Transglutaminase mediated conjugation of growth hormone |
| 02/11/2009 | CN101365478A Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 02/11/2009 | CN101365477A Pharmaceutical composition for treating haemorrhagic shock and its controlled-release capsules or tables |
| 02/11/2009 | CN101365476A Combined use of dpp iv inhibitors and gastrin compounds |
| 02/11/2009 | CN101365475A Treatment of multiple sclerosis using interferon-tau |
| 02/11/2009 | CN101365474A Interferon lambda therapy for treatment of respiratory diseases |
| 02/11/2009 | CN101365473A Pharmaceutical composition for treating or preventing ovarian cancer |
| 02/11/2009 | CN101365472A LOPAP-based pharmaceutical compositions and uses thereof |
| 02/11/2009 | CN101365471A Effect of bri proteins on abeta production |
| 02/11/2009 | CN101365470A Compositions and methods for treatment of diabetes |
| 02/11/2009 | CN101365469A Methods of treating obesity using enterostatin |
| 02/11/2009 | CN101365468A Organ preservation and/or perfusion |
| 02/11/2009 | CN101365467A Thrombin purification |
| 02/11/2009 | CN101365466A Zingiber plant extract |
| 02/11/2009 | CN101365335A Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 02/11/2009 | CN101362803A Fusion proteins of tick anticoagulant peptide and staphylococcus aureus superantigen-like protein, preparation and application thereof |
| 02/11/2009 | CN101362798A Candida albicans hyphal development inhibitor and application thereof |
| 02/11/2009 | CN101362797A Thrombopoietin mimic peptide, preparation and application thereof |
| 02/11/2009 | CN101362793A Prodrugs of excitatory amino acids |
| 02/11/2009 | CN101361978A Anti-cancer medicine release system using cellular membrane biomimetic modification polyamide-amide as carrier and preparation method thereof |
| 02/11/2009 | CN101361972A Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 02/11/2009 | CN101361970A Composition with beauty effect and health care efficacy and use thereof |
| 02/11/2009 | CN101361969A Therapeutic hepatitis b vaccine and preparation method and use thereof |
| 02/11/2009 | CN101361968A Use of interleukin-22 in treating fatty liver |
| 02/11/2009 | CN101361967A Y2/Y4 selective receptor agonists for therapeutic interventions |
| 02/11/2009 | CN101361966A Use of decorin in preparing medicine for treating ischemic cerebrovascular disease |
| 02/11/2009 | CN101361965A Use of vasodilator-stimulated phosphoprotein in preparing medicine for preventing and treating tumour in digestive system |
| 02/11/2009 | CN101361964A Use of vasodilator-stimulated phosphoprotein in preparing medicine for preventing and treating lung cancer and breast cancer |
| 02/11/2009 | CN101361963A Preparation method of protein and peptide drugs slow-release microcapsules |
| 02/11/2009 | CN101361962A New use of thymosin alpha1 |
| 02/11/2009 | CN101361961A Use of polypeptides micro-molecule in preparing medicine for preventing and treating ischemic cerebrovascular disease |
| 02/11/2009 | CN101361881A Use of Chinese potato as protein medicine lysozyme intestinal-tract sorbefacient |
| 02/11/2009 | CN101361804A Enteral nutrition emulsion for tumor patient |
| 02/11/2009 | CN101361717A Batroxobin freeze-dry powder injection and preparation method thereof |
| 02/11/2009 | CN100460874C Method for sieving crimp-relevant protain activator or antagonist |
| 02/11/2009 | CN100460509C Trichina paramyosin gene and application thereof |
| 02/11/2009 | CN100460382C Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril |
| 02/11/2009 | CN100460014C Helicobacter pylori vaccine based on urease B subunit active segment and prepn process thereof |
| 02/10/2009 | US7488816 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same |
| 02/10/2009 | US7488814 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 02/10/2009 | US7488809 Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest |
| 02/10/2009 | US7488805 Apoptosis proteins |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |
| 02/10/2009 | US7488801 Interferon-alpha polypeptides and conjugates |
| 02/10/2009 | US7488800 Isolated water soluble VP1 polypeptide of foot and mouth viral disease; containing sequence number 3; cancer, reperfusion injuries; neurodegenerative, autoimmune and immunodeficiency diseases; activating procaspase 9, 7 or 3 |
| 02/10/2009 | US7488798 Cancers of the breast, prostate, colorectal, lung, thyroid, ovaries, and brain as well as in childhood leukaemias, glioblastomas, and neuroblastomas; Insulin-like Growth Factor Binding Protein (IGFBP) with reduced IGF (Insulin-like Growth Factor) release characteristics |
| 02/10/2009 | US7488796 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins |
| 02/10/2009 | US7488793 Isolated peptide which binds to HLA-Cw*07 and uses thereof |
| 02/10/2009 | US7488791 capable of stimulating the production of anti-HPV T CD4+ lymphocytes for vaccination against uterine of uterus cancer or as diagnostic reagent of HPV-specific T lymphocytes, in particular for assessing the immune condition of patients |
| 02/10/2009 | US7488749 Therapy of diseases of the eye, the inner ear and the central nervous system |
| 02/10/2009 | US7488718 Synthetic HLA binding peptide analogues and uses thereof |
| 02/10/2009 | US7488717 Methods of inhibiting chemokine binding to chemokine receptors |
| 02/10/2009 | US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/10/2009 | US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488713 Cancer treatment using C-type natriuretic peptides |
| 02/10/2009 | US7488712 Histone deacetylase inhibitors and methods for producing the same |